RankingsPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited
  3. Financials
  4. Common stock and paid-in capital

SymBio Pharmaceuticals Limited【JP:4582】

Market cap
¥4.4B
P/E ratio
-0.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCommon stock and paid-in capital (Million JPY)YoY (%)
Dec 31, 202436,649+2.14%
Dec 31, 202335,880+2.31%
Dec 31, 202235,072+2.28%
Dec 31, 202134,290+0.66%
Dec 31, 202034,064+14.64%
Dec 31, 201929,714+14.66%
Dec 31, 201825,915+20.57%
Dec 31, 201721,493+8.19%
Dec 31, 201619,867+19.45%
Dec 31, 201516,632+0.00%
Dec 31, 201416,632

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)